Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Potent and selective integrin inhibitors reported by Celltech

Aug. 28, 2001

Pharmacia presents a potent MMP inhibitor at ACS meeting in Chicago

Aug. 28, 2001

Potent, orally bioavailable FTase inhibitors discovered at Aventis

Aug. 28, 2001

CA4P development program continues as planned

Aug. 28, 2001

Sterix patents novel steroid sulfatase inhibitors

Aug. 27, 2001

Schering-Plough highlights next-generation farnesyl protein transferase inhibitors at ACS meeting

Aug. 27, 2001

Study of Cytran's IM-862 in ovarian cancer begins at Magee-Womens Hospital

Aug. 27, 2001

Lilly and Isis establish antisense strategic alliance

Aug. 27, 2001

Novogen to initiate clinical trial of oral phenoxodiol in advanced prostate cancer

Aug. 27, 2001

A new series of MMP inhibitors described by Darwin Discovery

Aug. 24, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...